R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule
De Clerck, F.; Beetens, J.; de Chaffoy de Courcelles, D.; Vercammen, E.; Freyne, E.; Janssen, P.A.
Progress in Clinical and Biological Research 301: 567-572
1989
ISSN/ISBN: 0361-7742 PMID: 2529556 Document Number: 329318
Document emailed within 1 workday
Related Documents
Gresele, P.; Van Houtte, E.; Arnout, J.; Deckmyn, H.; Vermylen, J. 1984: Thromboxane synthase inhibition combined with thromboxane receptor blockade: a step forward in antithrombotic strategy? Thrombosis and Haemostasis 52(3): 364Hoet, B.; Arnout, J.; Vermylen, J. 1989: R68070, a combined thromboxane/endoperoxide receptor antagonist (TRA) and thromboxane synthase inhibitor (TSI), prolongs the bleeding time more than aspirin in man Progress in Clinical and Biological Research 301: 573-577
Golino, P.; Ambrosio, G.; Gresele, P.; Pascucci, I.; Ragni, M.; Russolillo, E.; Leproux, G.B.; Chiariello, M. 1993: The in vivo antiplatelet effects of thromboxane A2 synthase inhibitors are potentiated by simultaneous thromboxane A2/prostaglandin H2 receptor blockade Journal of Pharmacology and Experimental Therapeutics 266(2): 511-517
Weber, C.; Beetens, J.R.; Tegtmeier, F.; Van Rooy, P.; Vercammen, E.; Wouters, L.; De Clerck, F. 1992: Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man Thrombosis and Haemostasis 68(2): 214-220
Chiabrando, C.; Broggini, M.; Castelli, M.G.; Cozzi, E.; Castagnoli, M.N.; Donelli, M.G.; Garattini, S.; Giavazzi, R.; Fanelli, R. 1987: Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor Cancer Research 47(4): 988-991
Basevich, V.V.; Mevkh, A.T.; Varfolomeev, S.D. 1984: Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets Biokhimiia 49(9): 1538-1545
Nakayama, D.; Ikeda, T. 1988: Effect of OKY-046, a thromboxane synthetase inhibitor, on renal thromboxane synthesis in spontaneously hypertensive rat Nihon Jinzo Gakkai Shi 30(1): 79-84
Mehta, J.; Mehta, P.; Lawson, D.L.; Ostrowski, N.; Brigmon, L. 1985: Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides Journal of Laboratory and Clinical Medicine 106(3): 246-252
Longhofer, S.L.; Frisbie, D.D.; Johnson, H.C.; Culham, C.A.; Cooley, A.J.; Schultz, K.T.; Grauer, G.F. 1991: Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis American Journal of Veterinary Research 52(3): 480-487
Murayama, K.; Kasai, H.; Adachi, T.; Utsunomiya, O.; Ouchi, H. 1983: Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs Nihon Sanka Fujinka Gakkai Zasshi 35(3): 344-350
Welch, W.J.; Wilcox, C.S.; Dunbar, K.R. 1989: Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic American Journal of Physiology 257(4 Pt 2): F554-F560
Holmsen, H. 1977: Prostaglandin endoperoxide--thromboxane synthesis and dense granule secretion as positive feedback loops in the propagation of platelet responses during "the basic platelet reaction" Thrombosis and Haemostasis 38(4): 1030-1041
Cohen, S.M.; Zenser, T.V.; Murasaki, G.; Fukushima, S.; Mattammal, M.B.; Rapp, N.S.; Davis, B.B. 1981: Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase Cancer Research 41(9 Part 1): 3355-3359
Wisner, D.; Sturm, J.; Sutter, G.; Ellendorf, B.; Nerlich, M. 1988: Thromboxane receptor blockade in an animal model of ARDS Surgery 104(1): 91-97
Ennis, C.; Granger, S.E.; Middlefell, V.C.; Philpot, M.E.; Shepperson, N.B. 1989: Pharmacologic effects of Wy 27569: a combined calcium channel blocker and thromboxane synthetase inhibitor Journal of Cardiovascular Pharmacology 13(4): 511-519
Rossini, M.; Belloni, A.; Remuzzi, G.; Perico, N. 1990: Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation Circulation 81(1): I61
Zenser, T.V.; Mattammal, M.B.; Davis, B.B. 1980: Mechanism of FANFT cooxidation by prostaglandin endoperoxide synthetase Journal of Pharmacology and Experimental Therapeutics 214(2): 312-317
Smith, J.B. 1987: Pharmacology of thromboxane synthetase inhibitors Federation Proceedings 46(1): 139-143
Nanji, A.A.; Rahemtulla, A.; Maio, L.; Khwaja, S.; Zhao, S.; Tahan, S.R.; Thomas, P. 1997: Alterations in thromboxane synthase and thromboxane A2 receptors in experimental alcoholic liver disease Journal of Pharmacology and Experimental Therapeutics 282(2): 1037-1043
Wilkes, B.M.; Hollander, A.M.; Sung, S.Y.; Mento, P.F. 1992: Cyclooxygenase inhibitors blunt thromboxane action in human placental arteries by blocking thromboxane receptors American Journal of Physiology 263(4 Pt 1): E718-E723